Ajanta Pharma
Ajanta Pharma Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of a diverse range of formulations. Founded in 1973, the company has established a strong presence in various operational regions, including Asia, Africa, and the Middle East. Ajanta Pharma is renowned for its focus on therapeutic areas such as ophthalmology, dermatology, and pain management, offering unique products that cater to specific medical needs. With a commitment to quality and innovation, the company has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. Recognised for its robust market position, Ajanta Pharma continues to expand its global footprint, driven by a dedication to enhancing patient care through effective and affordable healthcare solutions.
DitchCarbon Score
How does Ajanta Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ajanta Pharma's score of 26 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ajanta Pharma's reported carbon emissions
In 2024, Ajanta Pharma reported total carbon emissions of approximately 46,999,960 kg CO2e, comprising about 6,390,220 kg CO2e from Scope 1 and about 40,007,740 kg CO2e from Scope 2 emissions. This represents a significant increase in emissions compared to 2023, where the company recorded approximately 5,184,740 kg CO2e from Scope 1 and about 51,847,350 kg CO2e from Scope 2, totalling around 56,032,000 kg CO2e. Over the past few years, Ajanta Pharma has shown fluctuations in its emissions. In 2022, the company emitted approximately 51,444,670 kg CO2e, with Scope 1 emissions at about 4,611,220 kg CO2e and Scope 2 emissions at around 46,633,150 kg CO2e. In 2021, the total emissions were approximately 45,157,660 kg CO2e, with Scope 1 at about 3,660,360 kg CO2e and Scope 2 at around 41,756,300 kg CO2e. Despite these figures, Ajanta Pharma has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company has not reported on Scope 3 emissions, which typically encompass indirect emissions from the supply chain and product use. Ajanta Pharma's emissions intensity, measured in terms of revenue, has varied, indicating a need for ongoing assessment and potential strategies to enhance sustainability practices. The company continues to operate within the pharmaceutical industry, which is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 3,660,360 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 41,756,300 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ajanta Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
